Health ❯Obesity

Treatment Options

Treatment Options Pharmaceuticals Drug Development Obesity Pharmaceuticals Weight Management Market Competition Patient Care Pricing Strategies FDA Regulations

3 ARTICLES

4d ago

Bariatric Surgery Outperforms GLP-1 Medications in Sustained Weight Loss

Real-world data reveal that surgery leads to five times more weight loss with a lower risk of psychiatric disorders despite the surge in GLP-1 prescriptions.

3 ARTICLES

last mo.

Former Weight Watchers Leader Nears Weight Goal After Mounjaro Success

14 ARTICLES

last mo.

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

10 ARTICLES

last mo.

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

Treatment Options

Bariatric Surgery Outperforms GLP-1 Medications in Sustained Weight Loss

Former Weight Watchers Leader Nears Weight Goal After Mounjaro Success

Novo Nordisk Revises 2025 Outlook as FDA Crackdown and Competition Reshape Wegovy Market

UK to Trial Pharmacy-Based NHS Weight-Loss Jab Prescriptions

UK Nears One Million Users of Weight-Loss Jabs as New Benefits and Risks Emerge

Roche and Zealand Partner in $5.3 Billion Deal for Obesity Drug Development

AbbVie Enters Obesity Drug Market with $2.2 Billion Licensing Deal

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025